Saturday, October 24, 2020
The US Food and Drug Administration on Thursday issued a full approval of the antiviral drug remdesivir for treating COVID-19 -- just days after a massive global study concluded that the drug provides no benefit.
Admin's note: Participants in this discussion must follow the site's moderation policy. Profanity will be filtered. Abusive conduct is not allowed.